254 related articles for article (PubMed ID: 25504636)
21. The small GTPase RhoG mediates glioblastoma cell invasion.
Kwiatkowska A; Didier S; Fortin S; Chuang Y; White T; Berens ME; Rushing E; Eschbacher J; Tran NL; Chan A; Symons M
Mol Cancer; 2012 Sep; 11():65. PubMed ID: 22966858
[TBL] [Abstract][Full Text] [Related]
22. Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.
Aroui S; Aouey B; Chtourou Y; Meunier AC; Fetoui H; Kenani A
Chem Biol Interact; 2016 Jan; 244():195-203. PubMed ID: 26721195
[TBL] [Abstract][Full Text] [Related]
23. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3 acts upstream of ADP-ribosylation factor 6 and Rac1 to regulate epithelial cell migration.
Farooqui R; Zhu S; Fenteany G
Exp Cell Res; 2006 May; 312(9):1514-25. PubMed ID: 16529739
[TBL] [Abstract][Full Text] [Related]
25. Girdin, an actin-binding protein, is critical for migration, adhesion, and invasion of human glioblastoma cells.
Gu F; Wang L; He J; Liu X; Zhang H; Li W; Fu L; Ma Y
J Neurochem; 2014 Nov; 131(4):457-69. PubMed ID: 25060559
[TBL] [Abstract][Full Text] [Related]
26. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme.
Atkins RJ; Stylli SS; Luwor RB; Kaye AH; Hovens CM
J Clin Neurosci; 2013 Sep; 20(9):1185-92. PubMed ID: 23768967
[TBL] [Abstract][Full Text] [Related]
28. Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization.
Crean JK; Furlong F; Finlay D; Mitchell D; Murphy M; Conway B; Brady HR; Godson C; Martin F
FASEB J; 2004 Oct; 18(13):1541-3. PubMed ID: 15319369
[TBL] [Abstract][Full Text] [Related]
29. Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma.
Abe K; Yamamoto N; Domoto T; Bolidong D; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Inatani H; Aoki Y; Higuchi T; Taniguchi Y; Yonezawa H; Araki Y; Aiba H; Minamoto T; Tsuchiya H
Cancer Sci; 2020 Feb; 111(2):429-440. PubMed ID: 31808966
[TBL] [Abstract][Full Text] [Related]
30. Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy.
Xu W; Ge Y; Liu Z; Gong R
Am J Pathol; 2014 Oct; 184(10):2742-56. PubMed ID: 25239564
[TBL] [Abstract][Full Text] [Related]
31. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways.
Yang M; Gu YY; Peng H; Zhao M; Wang J; Huang SK; Yuan XH; Li J; Sang JL; Luo Q; Huang C
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1037-47. PubMed ID: 25432142
[TBL] [Abstract][Full Text] [Related]
32. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
33. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
34. Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression.
Tsai CF; Yeh WL; Chen JH; Lin C; Huang SS; Lu DY
Int J Mol Sci; 2014 Mar; 15(3):3889-903. PubMed ID: 24599080
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression.
Wu DG; Wang YY; Fan LG; Luo H; Han B; Sun LH; Wang XF; Zhang JX; Cao L; Wang XR; You YP; Liu N
Chin Med J (Engl); 2011 Sep; 124(17):2616-21. PubMed ID: 22040413
[TBL] [Abstract][Full Text] [Related]
36. Rac1 mediates phorbol 12-myristate 13-acetate-induced migration of glioblastoma cells via paxillin.
Nomura N; Nomura M; Mizuki N; Hamada J
Oncol Rep; 2008 Oct; 20(4):705-11. PubMed ID: 18813807
[TBL] [Abstract][Full Text] [Related]
37. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol inhibits glucose-induced migration of vascular smooth muscle cells mediated by focal adhesion kinase.
Lin YC; Chen LH; Varadharajan T; Tsai MJ; Chia YC; Yuan TC; Sung PJ; Weng CF
Mol Nutr Food Res; 2014 Jul; 58(7):1389-401. PubMed ID: 24659233
[TBL] [Abstract][Full Text] [Related]
39. The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in Glioblastoma.
Cheerathodi M; Avci NG; Guerrero PA; Tang LK; Popp J; Morales JE; Chen Z; Carnero A; Lang FF; Ballif BA; Rivera GM; McCarty JH
Mol Cancer Res; 2016 Dec; 14(12):1277-1287. PubMed ID: 27655131
[TBL] [Abstract][Full Text] [Related]
40. GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.
John JK; Paraiso KH; Rebecca VW; Cantini LP; Abel EV; Pagano N; Meggers E; Mathew R; Krepler C; Izumi V; Fang B; Koomen JM; Messina JL; Herlyn M; Smalley KS
J Invest Dermatol; 2012 Dec; 132(12):2818-27. PubMed ID: 22810307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
